X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (27) 27
humans (26) 26
index medicus (25) 25
female (19) 19
middle aged (18) 18
male (17) 17
aged (16) 16
adult (14) 14
cancer (11) 11
radiotherapy dosage (9) 9
aged, 80 and over (8) 8
prostate cancer (8) 8
radiotherapy (8) 8
retrospective studies (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
disease-free survival (6) 6
prostatic neoplasms - radiotherapy (6) 6
irradiation (5) 5
prospective studies (5) 5
radiology, nuclear medicine & medical imaging (5) 5
treatment outcome (5) 5
breast neoplasms - drug therapy (4) 4
breast neoplasms - radiotherapy (4) 4
care and treatment (4) 4
fluorouracil - administration & dosage (4) 4
follow-up studies (4) 4
survival rate (4) 4
toxicity (4) 4
vinblastine - administration & dosage (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
brachytherapy (3) 3
breast cancer (3) 3
breast neoplasms - surgery (3) 3
cancer therapies (3) 3
carcinoma, renal cell - drug therapy (3) 3
chemotherapy (3) 3
combined modality therapy (3) 3
intensity-modulated radiotherapy (3) 3
kidney neoplasms - drug therapy (3) 3
mastectomy (3) 3
medicine, general & internal (3) 3
nephrectomy (3) 3
original paper (3) 3
prognosis (3) 3
radiation (3) 3
radiotherapy planning, computer-assisted (3) 3
research (3) 3
therapy (3) 3
vinblastine (3) 3
5-fluorouracil (2) 2
abridged index medicus (2) 2
adjuvant (2) 2
adolescent (2) 2
antiemetics (2) 2
breast neoplasms - pathology (2) 2
carcinoma (2) 2
carcinoma, renal cell - secondary (2) 2
carcinoma, renal cell - surgery (2) 2
combination (2) 2
cyclophosphamide - adverse effects (2) 2
dexamethasone - administration & dosage (2) 2
double-blind method (2) 2
drug administration schedule (2) 2
drug therapy, combination (2) 2
external-beam radiotherapy (2) 2
fluorouracil - adverse effects (2) 2
heart attacks (2) 2
home-therapy (2) 2
immunochemotherapy (2) 2
interferon-alpha (2) 2
interferon-alpha - administration & dosage (2) 2
interleukin-2 - administration & dosage (2) 2
kidney neoplasms - pathology (2) 2
kidney neoplasms - surgery (2) 2
life sciences (2) 2
medical treatment (2) 2
metastatic renal cell carcinoma (2) 2
methods (2) 2
methotrexate - adverse effects (2) 2
metoclopramide - administration & dosage (2) 2
neoplasm recurrence, local (2) 2
neoplasm staging (2) 2
patients (2) 2
phase-ii (2) 2
phase-iii trial (2) 2
postmastectomy radiotherapy (2) 2
postoperative radiotherapy (2) 2
prostate (2) 2
prostatic neoplasms - drug therapy (2) 2
prostatic neoplasms - mortality (2) 2
prostatic neoplasms - pathology (2) 2
radiation therapy (2) 2
radiation-therapy (2) 2
radiology nuclear medicine and imaging (2) 2
radiotherapy, adjuvant (2) 2
radiotherapy, conformal (2) 2
randomized-trial (2) 2
rare diseases (2) 2
renal cell carcinoma (2) 2
resection (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 24, pp. 2516 - 2527
A current standard treatment for locally advanced prostate cancer is external-beam radiotherapy combined with 3 years of androgen suppression. Adverse events,... 
PHASE-III TRIAL | DEPRIVATION THERAPY | IRRADIATION | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | EORTC | RANDOMIZED-TRIAL | QUALITY-OF-LIFE | RADIOTHERAPY | RADIATION-THERAPY | ADJUVANT | Anilides - therapeutic use | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Anilides - adverse effects | Humans | Middle Aged | Male | Gonadotropin-Releasing Hormone - analogs & derivatives | Flutamide - adverse effects | Treatment Failure | Aged, 80 and over | Adult | Flutamide - therapeutic use | Prostatic Neoplasms - drug therapy | Drug Administration Schedule | Proportional Hazards Models | Combined Modality Therapy | Prostatic Neoplasms - mortality | Disease-Free Survival | Tosyl Compounds - adverse effects | Heart Diseases - mortality | Tosyl Compounds - therapeutic use | Quality of Life | Radiotherapy, Conformal - adverse effects | Aged | Androgen Antagonists - administration & dosage | Androgen Antagonists - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Heart attacks | Medical treatment | Mortality | Radiation therapy | Prostate cancer | Cancer therapies | Quality of life | Index Medicus | Abridged Index Medicus | Androgen Antagonists | Anilides | Life Sciences | Prostatic Neoplasms | Flutamide | Heart Diseases | Radiotherapy, Conformal | Gonadotropin-Releasing Hormone | Nitriles | Tosyl Compounds | Cancer
Journal Article
Journal Article
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 01/2016, Volume 34, Issue 2, pp. 260 - 260
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2016, Volume 34, Issue 15, pp. e16092 - e16092
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 01/2016, Volume 34, Issue 2, pp. 538 - 538
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 01/2016, Volume 34, Issue 2, pp. 539 - 539
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2015, Volume 33, Issue 15, pp. e15618 - e15618
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2014, Volume 32, Issue 15, pp. e15547 - e15547
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2014, Volume 32, Issue 15, pp. e15550 - e15550
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2014, Volume 32, Issue 15, pp. e15551 - e15551
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 02/2014, Volume 32, Issue 4, pp. 486 - 486
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 02/2014, Volume 32, Issue 4, pp. 508 - 508
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 02/2014, Volume 32, Issue 4, pp. 494 - 494
Conference Proceeding
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.